These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4755862)
1. [Clinical studies on the effects of rifampicin for bone and joint tuberculosis (author's transl)]. Sawamura K; Shimomura M Kekkaku; 1973 Aug; 48(8):357-63. PubMed ID: 4755862 [No Abstract] [Full Text] [Related]
2. [Clinical studies on the effects of rifampicin for severe bone and joint tuberculosis]. Otani K Kekkaku; 1973 Mar; 48(3):75-88. PubMed ID: 4721389 [No Abstract] [Full Text] [Related]
3. [Initial evaluation of the use of rifampicin in the treatment of bone and lymph node tuberculosis]. Duriez J; Debeaumont A Rev Chir Orthop Reparatrice Appar Mot; 1972; 58(1):21-32. PubMed ID: 4263541 [No Abstract] [Full Text] [Related]
4. [The effects of rifampicin on bone-joint tuberculosis with fistulation]. Kondo K; Kuze A; Usui M; Harada Y Kekkaku; 1973 Mar; 48(3):89-95. PubMed ID: 4721390 [No Abstract] [Full Text] [Related]
5. [Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol]. Suleĭmanov I; Prosvirova LA; Umarov B; Beliakova NK Probl Tuberk; 1981 Dec; (12):49-52. PubMed ID: 7335634 [No Abstract] [Full Text] [Related]
6. Local diffusibility of rifampicin in tuberculous lesions of bone and joint. Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795 [No Abstract] [Full Text] [Related]
7. Effect of cortisone on systemic reactions provoked by rifampicin. Mattson K; Riska N Scand J Respir Dis; 1972; 53(2):97-100. PubMed ID: 5052729 [No Abstract] [Full Text] [Related]
8. [Clinical studies on the effects of rifampicin for tuberculous lymphadenitis (author's transl)]. Aoyagi T; Maekawa N; Fukuhara T; Yamamoto M; Oosato T Kekkaku; 1973 Aug; 48(8):351-6. PubMed ID: 4755861 [No Abstract] [Full Text] [Related]
9. [Local therapeutic trials of various forms of extrapulmonary tuberculosis using rifampicin suspension]. Basacopol A; Burzoni FJ; Munteanu E Maroc Med; 1974 May; 54(579):314-6. PubMed ID: 4444315 [No Abstract] [Full Text] [Related]
10. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)]. Urakami E; Nagasawa S Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413 [No Abstract] [Full Text] [Related]
11. [A case of sternoclavicular joint tuberculosis with renal failure due to rifampicin]. Amano H; Takamori M; Fujita A; Sakashita K; Murata K; Miyamoto M; Wada A Kekkaku; 2009 Aug; 84(8):591-5. PubMed ID: 19764465 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect of rifampicin (RFP) on leprosy. I. Clinical effect (observation of twelve months) (author's transl)]. Repura; 1974; 43(1):8-25. PubMed ID: 4479678 [No Abstract] [Full Text] [Related]
13. [Acute renal insufficiency and interstitial nephritis caused by rifampicin. A comment on this subject]. Santacruz PL; Agüero F; León ME; Córdoba Z Nefrologia; 2001; 21(3):323. PubMed ID: 11471316 [No Abstract] [Full Text] [Related]
14. [A case of acute renal failure after readministration of rifampicin (author's transl)]. Harada T; Shinzato K; Taura K; Oda T; Ogata H; Fujimatsu S; Sho T; Hara K; Taguchi T; Takebayashi S Nihon Naika Gakkai Zasshi; 1980 Apr; 69(4):483-7. PubMed ID: 7391636 [No Abstract] [Full Text] [Related]
16. [Rifampicin concentration in the tissues of the musculoskeletal system]. Kheĭny I; Zagorska T; Ianik M; Melikher I Probl Tuberk; 1977 Apr; (4):67-9. PubMed ID: 877066 [No Abstract] [Full Text] [Related]
17. [Ascertained diagnosis in bone and bone-and-joint tuberculosis (author's transl)]. Martini M; Larbaoui D; Boulahbal F Ann Chir; 1975 Feb; 29(2):111-7. PubMed ID: 1167009 [No Abstract] [Full Text] [Related]
18. [Aggravation and relapse of tuberculosis before and after the clinical application of rifampicin (author's transl)]. Shimizu T Kekkaku; 1976 Dec; 51(12):507-8. PubMed ID: 1018407 [No Abstract] [Full Text] [Related]
19. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)]. Eule H; Iwainsky H Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430 [No Abstract] [Full Text] [Related]